Literature DB >> 16364824

Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end-stage renal disease.

Belinda Spoto1, Francesco A Benedetto, Alessandra Testa, Giovanni Tripepi, Francesca Mallamaci, Renke Maas, Rainer H Boeger, Carmine Zoccali, Rosa Maria Parlongo, Anna Pisano.   

Abstract

BACKGROUND: We investigated whether the eNOS G/T polymorphism (Glu298Asp variant) is linked to the severity of carotid atherosclerosis and whether it is independent of asymmetric dimethylarginine (ADMA) in determining vascular damage in patients with end-stage renal disease (ESRD).
METHODS: The eNOS polymorphism, ADMA, carotid intima-media thickness (IMT), and carotid artery (CCA) wall-to-lumen ratio (an indicator of arterial remodeling) were determined/measured in 131 patients with ESRD.
RESULTS: Both in the co-dominant and dominant model approach, IMT as well as CCA wall-to-lumen ratio were directly related to the T allele (P < or = .009) and these relationships held true in multiple linear regression analyses including ADMA and traditional and emerging risk factors. The relationship between eNOS genotypes and CCA wall-to-lumen ratio was further analyzed by a categorical approach and in a multiple logistic regression analysis, the odds ratio (OR) of increased CCA wall-to-lumen ratio was strongly associated to the T allele (codominant model: GG, OR = 1; GT, OR = 2.1; TT, OR = 8.2; P for trend = .01; dominant model: GG, OR = 1; GT and TT, OR = 2.7; P = .02).
CONCLUSIONS: The T allele of eNOS gene is an independent predictor of intimal lesions and vascular remodeling and it is associated with the severity of atherosclerosis independently of ADMA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16364824     DOI: 10.1016/j.amjhyper.2005.06.007

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

Review 1.  Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis.

Authors:  Claudio Napoli; Louis J Ignarro
Journal:  J Clin Pathol       Date:  2006-07-12       Impact factor: 3.411

2.  eNOS Glu298Asp Polymorphism and Endothelial Dysfunction in Patients with and without End-stage Renal Disease.

Authors:  Nevin İlhan; Kadir Ateş; Necip İlhan; Dilara Kaman; Hüseyin Çeliker
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

3.  Association of angiotensin-converting enzyme and endothelial Nitric Oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population.

Authors:  Feng-Ying Tang; Fu-You Liu; Xiong-Wei Xie
Journal:  Mol Cell Biochem       Date:  2008-07-16       Impact factor: 3.396

Review 4.  Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.

Authors:  Johannes Jacobi; Philip S Tsao
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

5.  4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase.

Authors:  Gen Kobashi; Kaori Ohta; Hideto Yamada; Akira Hata; Hisanori Minakami; Noriaki Sakuragi; Hiko Tamashiro; Seiichiro Fujimoto
Journal:  J Epidemiol       Date:  2009-10-17       Impact factor: 3.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.